CMS assigns Q codes to procedures, services, and supplies on a temporary basis. When a permanent code is assigned, the Q code is deleted and cross-referenced.

View All HCPCS Sections

• Q9968

  Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg

• Q9969

  Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose

• Q9970

  Injection, ferric carboxymaltose, 1mg

• Q9972

  Injection, epoetin beta, 1 microgram, (for esrd on dialysis)

• Q9973

  Injection, epoetin beta, 1 microgram, (non-esrd use)

• Q9974

  Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg

• Q9975

  Injection, factor viii fc fusion protein (recombinant), per iu

• Q9976

  Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron

• Q9977

  Compounded drug, not otherwise classified

• Q9978

  Netupitant 300 mg and palonosetron 0.5 mg

• Q9979

  Injection, alemtuzumab, 1 mg

• Q9980

  Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg

• Q9981

  Rolapitant, oral, 1 mg

• Q9982

  Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries

• Q9983

  Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries

• Q9984

  Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg

• Q9985

  Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg

• Q9986

  Injection, hydroxyprogesterone caproate, (makena), 10 mg

• Q9987

  Pathogen(s) test for platelets

• Q9988

  Platelets, pheresis, pathogen-reduced, each unit

• Q9989

  Ustekinumab, for intravenous injection, 1 mg

• Q9991

  Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg

• Q9992

  Injection, buprenorphine extended-release (sublocade), greater than 100 mg

• Q9993

  Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg

• Q9994

  In-line cartridge containing digestive enzyme(s) for enteral feeding, each

• Q9995

  Injection, emicizumab-kxwh, 0.5 mg

• Q9996

  Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg

• Q9997

  Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg

• Q9998

  Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg

• Q9999

  Injection, ustekinumab-aauz (otulfi), biosimilar, 1 mg

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/4/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.